68 Results for "

pyruvate-kinase

" in MedChemExpress (MCE) Product Catalog:
Products (68)

68 Results for "pyruvate-kinase" in MCE Product Catalog:

66
66 Publications Verification
Cat. No.: HY-N0822
CAS No.: 517-89-5
Synonyms: C.I. 75535; Isoarnebin 4
Shikonin is a major component of a Chinese herbal medicine named zicao. Shikonin is a potent TMEM16A chloride channel inhibitor with an IC50 of 6.5 μM . Shikonin is a specific pyruvate kinase M2 (PKM2) inhibitor and can also inhibit TNF-α and NF-κB pathway . Shikonin decreases exosome secretion through the inhibition of glycolysis . Shikonin inhibits AIM2 inflammasome activation .
55
55 Cited Publications
Cat. No.: HY-18657
CAS No.: 1221186-53-3
Synonyms: ML-265
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

TEPP-46 (ML-265) is a potent and selective pyruvate kinase M2 (PKM2) activator with an AC50 of 92 nM, showing little or no effect on PKM1, PKL and PKR .
27
27 Cited Publications
Cat. No.: HY-103617
CAS No.: 94164-88-2
Purity:  99.79%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 μM .
18
18 Cited Publications
Cat. No.: HY-19330
CAS No.: 1203494-49-8
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease Cancer

DASA-58 is a potential pyruvate kinase isozyme (PKM2) allosteric activator. DASA-58 can be used for the research of metabolism and kinds of cancer .
4
4 Cited Publications
Cat. No.: HY-126585
CAS No.: 3031-95-6
Purity:  99.57%
SAICAR is an intermediate of de novo purine nucleotide biosynthesis, activates pyruvate kinase isoform M2 (PKM2) in an isozyme-selective manner, with an EC50 of 0.3 mM. SAICAR stimulates PKM2 and promotes cancer cell survival in glucose-limited conditions .
3
3 Cited Publications
Cat. No.: HY-12689
CAS No.: 1260075-17-9
Purity:  99.84%
Synonyms: AG-348
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease

Mitapivat (AG-348) is an orally active pyruvate kinase allosteric activator. Mitapivat increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes, shows the potential to restore the activity of PK (pyruvate kinase)-deficient glycolytic pathways. Mitapivat can be used in study of PK deficiency .
2
2 Cited Publications
Cat. No.: HY-157395
CAS No.: 2361327-06-0
Purity:  98.59%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

malonyl-NAC increases cellular propylation, resulting in reduced endogenous GAPDH activity. malonyl-NAC increases GAPDH malonylation in cells and inhibits pyruvate kinase activity. In addition, malonyl-NAC limits the metabolism and proliferation of a highly glycolytic kidney cancer cell line harboring a tricarboxylic acid cycle mutation .
2
2 Cited Publications
Cat. No.: HY-P80870
Synonyms: PKM; OIP3; PK2; PK3; PKM2; pyruvate kinase isozymes M1/M2; Cytosolic thyroid hormone-binding protein; CTHBP; Opa-interacting protein 3; OIP-3; pyruvate kinase 2/3; pyruvate kinase muscle isozyme; Thyroid hormone-binding protein 1; THBP1; Tu

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human, Mouse, Rat

1
1 Cited Publications
Cat. No.: HY-P7803
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: rHupyruvate kinase M2/PKM2, His; pyruvate kinase M2; PKM2; CTHBP; OIP-3; THBP1
Species:  
Source:  
Cat. No.: HY-W712327
CAS No.: 105931-44-0
Research Areas:  

Others

D-Xylulose 5-phosphate sodium is a pentose phosphate ester and an essential intermediate metabolite in the pentose phosphate pathway (PPP) and the non-oxidative phase of the pentose phosphate pathway. D-xylulose-5-phosphate sodium can be efficiently synthesized through the phosphorylation of D-xylulose catalyzed by D-xylulokinase (XKS1 from Saccharomyces cerevisiae), with ATP regeneration facilitated by the phosphoenolpyruvate (PEP)/pyruvate kinase (PK) system .
Cat. No.: HY-P2806
CAS No.: 9001-59-6
Synonyms: PK; Fluorokinase
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease Cancer

Pyruvate Kinase, Microorganism (PK) is a glycolytic enzyme that catalyzes the conversion of phosphoenolpyruvate and ADP to pyruvate and ATP .
Cat. No.: HY-P2806A
CAS No.: 9001-59-6
Synonyms: ATP:pyruvate 2-0-phosphotransferase,PK
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease Cancer

Pyruvate Kinase (PK),Rabbit Muscle (ATP:Pyruvate 2-0-phosphotransferase,PK) is a biological material or organic compound that can be used in life science research .
Cat. No.: HY-138825
CAS No.: 1039980-33-0
Purity:  ≥95.0%
Target:  

Pyk2

Research Areas:  

Metabolic Disease

NCGC00188636 is a novel covalent pyruvate kinase (PYK) inhibitor. NCGC00188636 blocks nucleotide binding to the active site of pyruvate kinase. NCGC00188636 can be used for the research of the metabolism of many organisms and cell types.
Cat. No.: HY-135884
CAS No.: 2283422-04-6
Purity:  99.12%
Synonyms: AG-946; PKR activator 2
Target:  

Pyruvate Kinase

Research Areas:  

Cardiovascular Disease

Tebapivat (PKR activator 2) is a potent pyruvate kinase-R (PKR) activator extracted from patent WO2019035863A1, compound 385 .
Cat. No.: HY-139573
CAS No.: 2245053-57-8
Purity:  99.91%
Synonyms: FT-4202
Target:  

Pyruvate Kinase

Research Areas:  

Cardiovascular Disease

Etavopivat is a potent, selective, and orally active erythrocyte pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects that can be used in studies of sickle cell disease and other haemoglobinopathies .
Cat. No.: HY-167832
CAS No.: 2059104-90-2
PT109 is an orally active, blood-brain barrier permeable multi-kinase inhibitor. By inhibiting PTBP1, PT109 promotes the switch of pyruvate kinase isoform from PKM2 to PKM1, thereby effectively inhibiting the proliferation and migration of glioblastoma multiforme and inducing its reprogramming into oligodendrocytes. PT109 also targets and regulates key signaling molecules such as JNK, SGK1, GSK3β to exert neuroprotective effects including promoting neurogenesis, inducing synapse formation and alleviating neuroinflammation. In Alzheimer's disease models, PT109 exhibits significant efficacy in improving spatial learning ability, along with excellent in vivo pharmacokinetic properties. PT109 can be used to investigate metabolic reprogramming of glioblastoma multiforme and neuroprotective mechanisms of Alzheimer's disease .
Cat. No.: HY-147368
CAS No.: 1186660-06-9
Purity:  99.48%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

PKM2 activator 2 (compound 28) is a pyruvate kinase M2 (PKM2) activitor with an AC50 value of 66 nM. PKM2 activator 2 can restore normal glycolytic metabolism in cells .
Cat. No.: HY-148615
CAS No.: 1040706-91-9
Purity:  99.69%
Target:  

Pyruvate Kinase

Research Areas:  

Cancer

NPD10084 is a pyruvate kinase PKM2 inhibitor that inhibits non-glycolytic signaling in cancer cells. NPD10084 disrupts the interaction between PKM2 and β-catenin or STAT3 and inhibits downstream signaling. NPD10084 has antiproliferative activity against colorectal cancer cells in vitro and in vivo .
Cat. No.: HY-19702
CAS No.: 1628428-01-2
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease

PKR activator 3 (Compound 160) is a red blood cell pyruvate kinase (PKR) activator. PKR activator 3 can be used in the research of diseases related to PKR function, such as pyruvate kinase deficiency (PKD) .
Cat. No.: HY-161337
CAS No.: 3078059-66-9
Target:  

Pyruvate Kinase

Research Areas:  

Metabolic Disease

PKL-IN-1 is a potent inhibitor of pyruvate kinase (PKL) with an IC50 of 0.07 μM. PKL-IN-1 can be used in the study of non-alcoholic fatty liver disease .